Alex Thurman
Director of Finance/CFO bei GLAUKOS CORPORATION
Vermögen: 5 Mio $ am 31.03.2024
Profil
Alex Thurman is currently the Chief Financial Officer & Senior Vice President at Glaukos Corp.
and the Vice President-Finance at Allergan Ltd.
(Ireland).
He has an undergraduate and graduate degree from Brigham Young University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLAUKOS CORP
0,11% | 08.04.2024 | 52 532 ( 0,11% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Alex Thurman
| Unternehmen | Position | Beginn |
|---|---|---|
| GLAUKOS CORPORATION | Director of Finance/CFO | 01.04.2022 |
| ALLERGAN PLC | Director of Finance/CFO | 01.12.2016 |
Ausbildung von Alex Thurman
| Brigham Young University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
